Press ReleasesHome / Who We Are / Goodwin Biotechnology in the News / Press Releases Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer February 16, 2022 Goodwin Biotechnology CEO Karl Pinto on Delivering Integrated Manufacturing Solutions for Complex Biopharmaceuticals October 19, 2020 AST and Goodwin Biotechnology Partner on a GENiSYS® C20 Aseptic Small Batch Filling & Closing Machine September 14, 2020 GigaGen Initiates Large-Scale Manufacturing of its First-in-Class RecombinantHyperimmune Drug for COVID-19, GIGA-2050 September 9, 2020 Goodwin Biotechnology Launches a Digitization Initiative by Investing in a Sophisticated Electronic Quality Solution November 6, 2019 Goodwin Biotechnology Announces the Appointment of Kent Payne, Ph.D. and Brandon Price, Ph.D. to its Board of Directors August 19, 2019 Goodwin Biotechnology Secures Significant Institutional Investment in New Round of Growth Capital Financing April 22, 2019 Radimmune Therapeutics Selected Goodwin Biotechnology for Process Development through cGMP Manufacturing of their IgG Monoclonal Antibody and Conjugate. November 14, 2018 Telix Pharmaceuticals Selects Goodwin Biotechnology as Manufacturing Scale‐up Partner May 2, 2018 Goodwin Biotechnology was named “Biologics cGMP Manufacturer of the Year 2018” by Global Health & Pharma News March 20, 20181 2 3 … 5 Next
